We are live on ! Find out more
PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

Back to rankings

120 hedge funds and large institutions have $262M invested in Progenics Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

1% less funds holding

Funds holding: 121 → 120 (-1)

10% less call options, than puts

Call options by funds: $833K | Put options by funds: $928K

18% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 44

32% less capital invested

Capital invested by funds: $383M → $262M (-$121M)

Holders
120
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
3.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
36
Reduced
44
Closed
16
Calls
$833K
Puts
$928K
Net Calls
-$95K
Net Calls Change
-$405K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.72M
2
SM
Sabby Management
Florida
+$1.54M
3
ACP
Acuta Capital Partners
California
+$1.04M
4
KAM
Kavi Asset Management
New York
+$1.01M
5
ARTA
A.R.T. Advisors
New York
+$969K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.3M
2
NI
Numeric Investors
Massachusetts
-$2.98M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.69M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.61M
5
State Street
State Street
Massachusetts
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.08M +$12.3K +2,773 +1%
TI
27
Turner Investments
Pennsylvania
$1.03M -$70.9K -15,929 -6%
ACP
28
Acuta Capital Partners
California
$1.01M +$1.04M +232,800 New
NI
29
Numeric Investors
Massachusetts
$992K -$2.98M -669,570 -75%
KAM
30
Kavi Asset Management
New York
$984K +$1.01M +225,700 New
TCIM
31
TIAA CREF Investment Management
New York
$938K -$50K -11,225 -5%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$907K -$55.7K -12,500 -6%
American Century Companies
33
American Century Companies
Missouri
$752K +$718K +161,327 +1,443%
Fisher Asset Management
34
Fisher Asset Management
Washington
$683K – – –
CCM
35
Cadence Capital Management
Massachusetts
$679K +$123K +27,610 +22%
Deutsche Bank
36
Deutsche Bank
Germany
$671K -$30.1K -6,756 -4%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$661K -$1.18K -264 -0.2%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$643K +$82.2K +18,456 +14%
AllianceBernstein
39
AllianceBernstein
Tennessee
$631K +$188K +42,170 +41%
SAMC
40
Shinko Asset Management Company
Japan
$611K – – –
TC
41
TFS Capital
Pennsylvania
$592K -$1.17M -262,480 -66%
Swiss National Bank
42
Swiss National Bank
Switzerland
$487K +$94.4K +21,200 +22%
SO
43
STRS Ohio
Ohio
$469K – – –
SC
44
Searle & Co
Connecticut
$463K +$200K +45,000 +75%
VEA
45
Virtus ETF Advisers
New York
$453K – – –
Thrivent Financial for Lutherans
46
Thrivent Financial for Lutherans
Minnesota
$450K – – –
Charles Schwab
47
Charles Schwab
California
$448K – – –
TA
48
Teachers Advisors
New York
$444K – – –
NC
49
Nexthera Capital
New York
$419K +$428K +96,000 New
BA
50
BlackRock Advisors
Delaware
$410K +$12K +2,686 +3%
1
2
3 4 5

PGNX Hedge Fund Activity: Q1 2016 in Review

120 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Progenics Pharmaceuticals Inc (PGNX) for Q1 2016, worth a combined $262M — down 32% from $383M a quarter earlier.

Fund positioning in PGNX was balanced in Q1 2016: 16 funds opened new positions, 16 closed out, 36 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.72M. The largest seller was Fidelity Investments, cutting an estimated $4.3M.

  • 120 institutional investors held Progenics Pharmaceuticals Inc (PGNX) as of Q1 2016, down from 121 in Q4 2015.
  • Funds reported $262M of Progenics Pharmaceuticals Inc stock for Q1 2016, down 32% quarter-over-quarter.
  • 16 funds opened new Progenics Pharmaceuticals Inc positions in Q1 2016 and 16 closed out, a net change of 0 holders.
  • The largest Progenics Pharmaceuticals Inc buyer in Q1 2016 was Millennium Management, an estimated $1.72M added.
  • The largest Progenics Pharmaceuticals Inc seller in Q1 2016 was Fidelity Investments, an estimated $4.3M sold.

Based on aggregated 13F filings for Q1 2016.